Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer

Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer

Background and objective: Toxicity from local salvage therapy for radiorecurrent prostate cancer (PCa) remains a concern. This phase 2 study evaluates the outcomes of salvage magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (sTULSA). Methods: Men with biochemically relapsed,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mikael Anttinen, Pietari Mäkelä, Pertti Nurminen, Heikki Pärssinen, Simona Malaspina, Teija Sainio, Mikael Högerman, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	European Urology Open Science
Subjects:	Ablation therapy Biochemical recurrence Local recurrence Magnetic resonance imaging–guided transurethral ultrasound ablation Prostate cancer Radiorecurrent prostate cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S266616832401423X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

The accuracy of ultrasensitive PSA in predicting disease progression after radical prostatectomy
by: Heikki Seikkula, et al.
Published: (2024-11-01)

Focal Therapy for Prostate Cancer: Recent Advances and Insights
by: Francesco Lasorsa, et al.
Published: (2024-12-01)

IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
by: V. B. Filimonov, et al.
Published: (2019-06-01)

Management of Recurrent Osteoid Osteoma: Case Report
by: Trupthi Das, et al.

Transurethral Water Vapor Ablation: Potential for a Novel Prostate Cancer Management Strategy
by: Warlick CA, et al.
Published: (2025-02-01)

A partial differential equation model of metastasized prostatic cancer
by: Avner Friedman, et al.
Published: (2013-03-01)

Magnetic Resonance Imaging Techniques for Post-Treatment Evaluation After External Beam Radiation Therapy of Prostate Cancer: Narrative Review
by: Eleni Bekou, et al.
Published: (2024-12-01)

Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer
by: Chung-Shih Chen, et al.
Published: (2024-12-01)

Prognostic significance of the logistic regression model for assessing the risk of recurrence in patients with prostate cancer after radical prostatectomy
by: S. A. Reva, et al.
Published: (2022-12-01)

Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk
by: Fahad M. Aldakheel, et al.
Published: (2025-02-01)

The preoperative neutrophil‐to‐lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy
by: Zhi Cao, et al.
Published: (2019-03-01)

Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases
by: Ji-Chen Wang, et al.
Published: (2024-12-01)

High Detection Rates for Prostate-specific Membrane Antigen–avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
by: Sarah Thomas, et al.
Published: (2025-01-01)

Risk factors for the recurrence of atrial fibrillation after catheter ablation: a meta-analysis
by: Gonghao Li, et al.
Published: (2025-01-01)

Complications of microwave ablation in patients with persistent/recurrent hyperparathyroidism after surgical or ablative treatment
by: Ying Wei, et al.
Published: (2024-12-01)

Applying Focal Therapy to Lesions Detected via Magnetic Resonance Imaging: Delivering Cancer Ablation Beyond the Visibility Phenomenon
by: Clement Orczyk, et al.
Published: (2025-02-01)

CHANGE IN TESTOSTERONE LEVELS IN ENDOSCOPIC OPERATIONS ON THE PROSTATE GLAND
by: E. A. Efremov, et al.
Published: (2018-06-01)

Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma
by: Toru Ishikawa, et al.
Published: (2024-12-01)

Risk factors for symptom recurrence after microwave ablation of adenomyosis: a preliminary retrospective study
by: Sainan Guan, et al.
Published: (2024-12-01)

The Impact of Atorvastatin on Intraprostatic Biomarkers – Prognostic Value of 3LS-score – Follow-up of ESTO1-Trial
by: Eemil Lehtonen, et al.
Published: (2025-03-01)

Impact of Centralisation of Radical Prostatectomy Driven by the Introduction of Robotic Systems on Positive Surgical Margin and Biochemical Recurrence in pT2 Prostate Cancer
by: Ibrahim Ibrahim, et al.
Published: (2025-01-01)

The factors impacting on Gleason score upgrading in prostate cancer with initial low Gleason scores
by: Tzu-Heng Huang, et al.
Published: (2025-02-01)

Impact of aspirin on biochemical recurrence of prostate cancer after robot assisted radical prostatectomy in a multicenter retrospective cohort study
by: Shuhei Suzuki, et al.
Published: (2025-01-01)

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

Association between prostate-specific antigen density and prostate cancer prediction among Nigerian men
by: Abudu EK, et al.
Published: (2025-01-01)

Variations in the diagnostic performance of transurethral resection of bladder tumor with photodynamic diagnosis according to surgical experience: A retrospective, single-center study
by: Shuhei Suzuki, et al.
Published: (2025-02-01)

Percutaneous cryoablation of kidney tumors after partial nephrectomy
by: Wojciech Krajewski, et al.
Published: (2024-10-01)

Multimodal data-based longitudinal prognostic model for predicting atrial fibrillation recurrence after catheter ablation in patients with patent foramen ovale and paroxysmal atrial fibrillation
by: Shoupeng Duan, et al.
Published: (2025-01-01)

Predictors of recurrence of ventricular tachycardia and the effectiveness of endocardial ablation at the patients with sudden cardiac death and history of myocardial infarction
by: O. M. Grytsay, et al.
Published: (2024-11-01)

Ultrasound-guided microwave ablation versus surgery for low-risk solitary papillary thyroid microcarcinoma: a propensity-matched cohort study
by: Yujie Ren, et al.
Published: (2025-01-01)

Safety and efficacy of indocyanine green fluorescence imaging for real-time guidance of laparoscopic thermal ablation in patients with liver cancer
by: Qitao Hu, et al.
Published: (2024-12-01)

Unveiling <i>DENND2D</i> as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis
by: Chi-Fen Chang, et al.
Published: (2024-12-01)

Long-term survival analysis of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma conforming to the Milan criteria: primary versus recurrent HCC
by: Jing Zhang, et al.
Published: (2024-12-01)

Microwave ablation for recurrent primary hyperparathyroidism in four patients with multiple endocrine neoplasia type 1: a case series report
by: Jie Tan, et al.
Published: (2024-12-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

The Novel Histological Prostatic Inflammation Score Helps Defining the Association Between Stromal and Glandular Inflammation with the Risk of Prostate Cancer at Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2025-01-01)

A Rare Metastasis of Prostate Cancer
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01)

Prostate Cancer Screening: Is it Recommended in 2024?
by: Dr. Ali Thwaini
Published: (2024-12-01)

Microbially produced imidazole propionate impairs prostate cancer progression through PDZK1
by: Shengkai Jin, et al.
Published: (2025-01-01)